If youre going to inject Ipamorelin only once per day, inject it before your workout its rapid onset (GH peak at ~40 minutes post-injection) makes it ideal as a pre-workout GH secretagogue
Abcam), anti-Oct3/4 (1:200 dilution
Now, a large-scale Scandinavian study has found no significant increase in thyroid cancer risk in those taking GLP-1 receptor agonists compared with those on other treatments for type 2 diabetes
Yes, it can help reduce the appearance of fine lines over time by signaling the skin to produce more collagen, but it works gradually and requires consistent use for several months
DIO ovariectomized female mice treated chronically with a stable estrogen/GLP-1 coagonist had significantly greater body weight and fat mass loss as compared to GLP-1R monagonists
What Reclassification Would (and Would Not) Change If BPC-157 is moved to Category 1 after the July 2026 meeting, the regulatory impact is narrower than many online summaries suggest: Scenario Category 2 (current default) Category 1 (post-reclassification) FDA approval No No 503A compounding Not permitted Permitted (pending final rulemaking) 503B outsourcing facilities Separate list (503B bulks list) Separate determination required Commercial drug product Not available Still not available without NDA Research/laboratory use Legal for research Legal for research (unchanged) In plain terms: Category 1 status lets a patient with a valid prescription get BPC-157 prepared by a state-licensed compounding pharmacy